227 related articles for article (PubMed ID: 3060792)
1. The expression of multiple proto-oncogenes is differentially regulated during retinoic acid induced maturation of human neuroblastoma cell lines.
Thiele CJ; Deutsch LA; Israel MA
Oncogene; 1988 Sep; 3(3):281-8. PubMed ID: 3060792
[TBL] [Abstract][Full Text] [Related]
2. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid induces down-regulation of several growth factors and proto-oncogenes in a human embryonal cancer cell line.
Miller WH; Moy D; Li A; Grippo JF; Dmitrovsky E
Oncogene; 1990 Apr; 5(4):511-7. PubMed ID: 2158037
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin.
Reed JC; Meister L; Tanaka S; Cuddy M; Yum S; Geyer C; Pleasure D
Cancer Res; 1991 Dec; 51(24):6529-38. PubMed ID: 1742726
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance.
Lasorella A; Iavarone A; Israel MA
Cancer Res; 1995 Oct; 55(20):4711-6. PubMed ID: 7553653
[TBL] [Abstract][Full Text] [Related]
6. Different regulation of N- and c-myc expression during phorbol ester-induced maturation of human SH-SY5Y neuroblastoma cells.
Hammerling U; Bjelfman C; Påhlman S
Oncogene; 1987; 2(1):73-7. PubMed ID: 3325885
[TBL] [Abstract][Full Text] [Related]
7. Multiple mechanisms of regulation of the human c-myb gene during myelomonocytic differentiation.
Boise LH; Gorse KM; Westin EH
Oncogene; 1992 Sep; 7(9):1817-25. PubMed ID: 1323820
[TBL] [Abstract][Full Text] [Related]
8. Increased retinoic acid receptor gamma expression suppresses the malignant phenotype and alters the differentiation potential of human neuroblastoma cells.
Marshall GM; Cheung B; Stacey KP; Camacho ML; Simpson AM; Kwan E; Smith S; Haber M; Norris MD
Oncogene; 1995 Aug; 11(3):485-91. PubMed ID: 7630632
[TBL] [Abstract][Full Text] [Related]
9. FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas.
Maerz WJ; Baselga J; Reuter VE; Mellado B; Myers ML; Bosl GJ; Spinella MJ; Dmitrovsky E
Oncogene; 1998 Aug; 17(6):761-7. PubMed ID: 9715278
[TBL] [Abstract][Full Text] [Related]
10. Regulated expression of Wnt family members during neuroectodermal differentiation of P19 embryonal carcinoma cells: overexpression of Wnt-1 perturbs normal differentiation-specific properties.
Smolich BD; Papkoff J
Dev Biol; 1994 Nov; 166(1):300-10. PubMed ID: 7958454
[TBL] [Abstract][Full Text] [Related]
11. Patterns of regulation of nuclear proto-oncogenes MYCN and MYB in retinoic acid treated neuroblastoma cells.
Thiele CJ
Prog Clin Biol Res; 1991; 366():151-6. PubMed ID: 2068135
[No Abstract] [Full Text] [Related]
12. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG
Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799
[TBL] [Abstract][Full Text] [Related]
13. Regulation of NGF responsiveness in human neuroblastoma.
Bogenmann E; Peterson S; Maekawa K; Matsushima H
Oncogene; 1998 Nov; 17(18):2367-76. PubMed ID: 9811468
[TBL] [Abstract][Full Text] [Related]
14. Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor.
Lavenius E; Gestblom C; Johansson I; Nånberg E; Påhlman S
Cell Growth Differ; 1995 Jun; 6(6):727-36. PubMed ID: 7669728
[TBL] [Abstract][Full Text] [Related]
15. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
St-Arnaud R; Nepveu A; Marcu KB; McBurney MW
Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960
[TBL] [Abstract][Full Text] [Related]
16. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid-induced growth arrest and differentiation of neuroblastoma cells are counteracted by N-myc and enhanced by max overexpressions.
Peverali FA; Orioli D; Tonon L; Ciana P; Bunone G; Negri M; Della-Valle G
Oncogene; 1996 Jan; 12(2):457-62. PubMed ID: 8570225
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 expression in neuroblastoma is differentially regulated by differentiation inducers.
Kim CJ; Kim HO; Choe YJ; Lee YA; Kim CW
Anticancer Res; 1995; 15(5B):1997-2000. PubMed ID: 8572591
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
Hanada M; Krajewski S; Tanaka S; Cazals-Hatem D; Spengler BA; Ross RA; Biedler JL; Reed JC
Cancer Res; 1993 Oct; 53(20):4978-86. PubMed ID: 8402688
[TBL] [Abstract][Full Text] [Related]
20. BMP-6 and retinoic acid synergistically differentiate the IMR-32 human neuroblastoma cells.
Sumantran VN; Brederlau A; Funa K
Anticancer Res; 2003; 23(2B):1297-303. PubMed ID: 12820386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]